Health Press Release – Weekly Newsletter for March 14-21, 2011
Keynote Speakers at eHealth Week 2011 Call for Significant IT Investments in the Health Systems of the Future
Move From Hospital-centric to Community-wide IT Solutions Will Change the Patient Experience of Healthcare; Delegate Registration in Progress
BUDAPEST, Hungary and BRUSSELS, March 14, 2011 - eHealth Week 2011 (ehealthweek.org/), revealed today the list of
keynote speakers who will address delegates at the "eHealth World-Cup", which
is to be held in Budapest, Hungary on 10-12 May, 2011. .... Original source : Keynote Speakers at eHealth Week 2011 Call for Significant IT Investments in the Health Systems of the Future.
Health Press Release – Weekly Newsletter for March 7-14, 2011
Marketsandmarkets: Global Food Safety Testing Market by Contaminants to be $ 4147 Million by 2015
DALLAS, March 7, 2011 - The Global Food Safety Testing Market By Contaminants, Technology, Food
Types, Geography: Trends & Forecast (2010 - 2015) analyzes the food safety
testing market by technology and applications and studies the major market
drivers, restraints, and opportunities for the food safety testing market in
North America, Europe, Asia, and ROW.
... Original source on Gaea Times at : Marketsandmarkets: Global Food Safety Testing Market by Contaminants to be $ 4147 Million by 2015.
Health Press Release – Weekly Newsletter for March 1-7, 2011
Stuttering Reigns King at the Oscars
MEMPHIS, Tennessee, February 28, 2011 - Jane Fraser, president, The Stuttering Foundation (www.stutteringhelp.org),
issued the following reaction to the Oscar awards:
"It is an eloquently golden night for people who stutter. The King's
Speech has been a godsend for the entire stuttering community.
"Tom Hooper gave us an inspirational hero, .... Source : Stuttering Reigns King at the Oscars.
Health Press Release – Weekly Newsletter for February 21-28, 2011
Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus
HUDDINGE, Sweden, February 22, 2011 - Medivir AB (OMX: MVIR), the emerging research-based specialty
pharmaceutical company focused on infectious diseases, announces today
further positive results from the phase 2b PILLAR (C205) study of TMC435 in
treatment-naive patients with hepatitis C virus (HCV) genotype-1.
- TMC435 was safe and well tolerated with no clinically
.... Source article on Gaea Times at : Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus.
Health Press Release – Weekly Newsletter for February 14-21, 2011
Medivir Signs Research & Development Collaboration on Dengue Virus
HUDDINGE, Sweden, February 14, 2011 - Highlights of the Collaboration:
- Collaboration with Janssen Pharmaceutica N.V. Focused on Dengue Virus
- Both Parties to Contribute 50:50 Resources to the Research Program
- Strengthens Medivir's Presence in Infectious Diseases And Utilises
... Read more >>>.